Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02347215
Other study ID # s11-00498
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2014
Est. completion date December 2019

Study information

Verified date February 2020
Source NYU Langone Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Serial assessment of angina status and ischemia on stress echo over one year among patients with moderate ischemia on stress imaging and non-obstructive CAD on coronary CT angiography.


Description:

Some people with chest pain are found to have open arteries on angiograms instead of blocked arteries and many, but not all, of these people have abnormal stress tests or other tests showing there is not enough blood flow to the heart. Prior research has not made clear whether chest pain in such patients is due to heart disease or something else, in part because no one has found out whether chest pain and stress test results change in the same direction over time. This study will use two measurements of chest pain and two stress tests, one year apart, to find out if chest pain and abnormal stress tests are both caused by the same problem: not enough blood flow to the heart.The association between angina, ischemia and atherosclerosis severity at baseline will be examined, as will medication effects.


Recruitment information / eligibility

Status Completed
Enrollment 212
Est. completion date December 2019
Est. primary completion date December 2019
Accepts healthy volunteers No
Gender All
Age group 21 Years to 100 Years
Eligibility Inclusion Criteria:

- Enrolled but not randomized in ISCHEMIA trial

- Stress echocardiography used for enrollment*

- No obstructive CAD on study coronary CT angiography (defined as no =50% stenosis in a major epicardial vessel)

- Ischemic symptoms (chest pain or other potential ischemic equivalent).

- Participant is willing to give written informed consent

- Age = 21 years

Exclusion Criteria:

- Inability to comply with protocol

- Prior PCI or CABG

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Quality of Life assessment
Seattle Angina Questionnaire and other questionnaires.
Procedure:
Stress imaging
Stress imaging

Locations

Country Name City State
United States NYU Medical Center and Bellevue Hospital Center New York New York

Sponsors (3)

Lead Sponsor Collaborator
NYU Langone Health Duke Clinical Research Institute, Massachusetts General Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Seattle Angina Questionnaire (SAQ) score baseline-one year comparison
Secondary Ischemia severity baseline-one year comparison
Secondary Coronary atherosclerosis severity (comparison with SAQ score and with ischemia severity) comparison with SAQ score and with ischemia severity baseline
Secondary Ischemia severity (comparison with SAQ score and with ischemia severity) comparison with SAQ score and with atherosclerosis severity baseline
Secondary Medical therapy used for angina (comparison with SAQ score and ischemia severity) comparison with SAQ score and ischemia severity one year
Secondary Major adverse cardiac events death, MI, stroke, cardiovascular hospitalizations/ER visits one year
See also
  Status Clinical Trial Phase
Completed NCT05563701 - Evaluation of the LVivo Image Quality Scoring (IQS)
Recruiting NCT02773615 - CT Perfusion Added to CT Angiography
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Terminated NCT02548611 - Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention Phase 4
Completed NCT02264717 - Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease N/A
Completed NCT02440893 - Understanding the Effect of Metformin on Corus CAD (or ASGES)
Completed NCT01425359 - Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina Phase 4
Completed NCT01486030 - Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test
Completed NCT01604486 - Natural Ischaemic Preconditioning Before First Myocardial Infarction N/A
Completed NCT00811772 - Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis N/A
Completed NCT00131183 - Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable Angina Phase 4
Completed NCT00184444 - Effect of Increased Oxygenation in the Air During Endurance Training in Stable Angina Pectoris Patients N/A
Completed NCT00235404 - Randomized Controlled Trial of Health Care to Elderly Patients. N/A
Terminated NCT00157742 - Comparison of SCS and PMR in Patients With Refractory Angina Pectoris Phase 4
Completed NCT00000510 - Platelet-Inhibitor Drug Trial in Coronary Angioplasty Phase 3
Completed NCT00005148 - Coronary Heart Disease Incidence, Mortality, and Risk Factor Relationships N/A
Not yet recruiting NCT03657758 - Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO] Phase 4
Completed NCT05050773 - Registry Study of Medical Therapy in Patients With Angina Pectoris(GREAT)
Completed NCT00093223 - A Safety Study of ABI-007 for In-Stent Restenosis Phase 2
Active, not recruiting NCT02508714 - Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents N/A